These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 398153)

  • 21. Letter: Bisolvon in chronic respiratory disease.
    Watson EW
    Med J Aust; 1974 Nov; 2(22):824-5. PubMed ID: 4456160
    [No Abstract]   [Full Text] [Related]  

  • 22. [A controlled study on the action of a new formulation of ambroxol in asthmatiform bronchitis in children].
    Baldini G; Gucci M; Tarò D; Memmini C
    Minerva Pediatr; 1989 Feb; 41(2):91-5. PubMed ID: 2661989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucolytic treatment of chronic bronchitis during two winter periods.
    Andreasen T
    Scand J Respir Dis Suppl; 1974; 90():69-70. PubMed ID: 4618376
    [No Abstract]   [Full Text] [Related]  

  • 24. Improvement of mucociliary transport in smokers by mucolytics.
    Olivieri D; Marsico SA; Del Donno M
    Eur J Respir Dis Suppl; 1985; 139():142-5. PubMed ID: 3862608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Modification of mucociliary clearance by a combination of theophylline with ambroxol and of ambroxol in monotherapy].
    Dorow P; Weiss T
    Arzneimittelforschung; 1988 Jun; 38(6):828-30. PubMed ID: 3052462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of oral salbutamol and ephedrine in chronic obstructive pulmonary disease.
    Kamat SR; Hoskote VR; Store SD; Sanghavi B; Sheth UK
    Indian J Chest Dis Allied Sci; 1978 Apr; 20(2):54-62. PubMed ID: 363609
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative clinical evaluation of two mucolytic agents: S-carboxy-methyl-cysteine and letosteine (author's transl)].
    Blaive B; Lapalus P; Lemoigne F
    Sem Hop; 1978 Oct 8-15; 54(29-32):983-6. PubMed ID: 216094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical study on Lasolvan in chronic obstructive pulmonary disease.
    Král B; Ellás J; Rozánek P; Jirkal J; Tilser P
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1981; 24(5):601-6. PubMed ID: 7051260
    [No Abstract]   [Full Text] [Related]  

  • 29. Functional and clinical evaluation of feprazonebromhexine association in bronchopulmonary diseases.
    Del Bono N; Quartieri F; Renda B; Sconosciuto F; Vibelli C
    Panminerva Med; 1978; 20(2):117-22. PubMed ID: 360150
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of bromhexine and guaiphenesine on clinical state, ventilatory capacity and sputum viscosity in chronic asthma.
    Heilborn H; Pegelow K-O ; Odeblad E
    Scand J Respir Dis; 1976; 57(2):88-96. PubMed ID: 781835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Steroid response after long-term treatment with oral N-acetylcysteine in patients with chronic obstructive bronchitis].
    Evald T; Hansen M; Balsløv S; Brorson-Riis L; Hansen NC; Maltbaek N; Thorshauge H
    Ugeskr Laeger; 1989 Nov; 151(46):2076-8. PubMed ID: 2688231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Combination of anticholinergic, beta-2-sympathomimetic agents and theophylline in the treatment of chronic obstructive lung disease. A double-blind multicenter study of 60 patients].
    Bezel R; Brändli O; Braun P; Haegi V; Helcl J; Villiger B
    Schweiz Rundsch Med Prax; 1987 May; 76(22):632-6. PubMed ID: 2956661
    [No Abstract]   [Full Text] [Related]  

  • 33. A double-blind placebo controlled trial with oral ambroxol and N-acetylcysteine for mucolytic treatment in cystic fibrosis.
    Ratjen F; Wönne R; Posselt HG; Stöver B; Hofmann D; Bender SW
    Eur J Pediatr; 1985 Nov; 144(4):374-8. PubMed ID: 3908111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlled clinical trial of a new dosage form of metaproterenol.
    Beck GJ
    Ann Allergy; 1980 Jan; 44(1):19-22. PubMed ID: 6986110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases.
    Boman G; Bäcker U; Larsson S; Melander B; Wåhlander L
    Eur J Respir Dis; 1983 Aug; 64(6):405-15. PubMed ID: 6350033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A between-patient, double-blind comparison of S-carboxymethylcysteine and bromhexine in chronic obstructive bronchitis.
    Aylward M
    Curr Med Res Opin; 1973; 1(4):219-27. PubMed ID: 4589629
    [No Abstract]   [Full Text] [Related]  

  • 37. Controlled endoscopic study on gastroduodenal safety of acetylcysteine after oral administration.
    Marini U; Visconti G; Spotti D; Geniram A
    Eur J Respir Dis Suppl; 1980; 111():147-50. PubMed ID: 7011833
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of onset of bronchodilating effect by interruption of the air flow method.
    Lulling J; Delwiche JP; Prignot J
    Eur J Respir Dis; 1980 Apr; 61(2):108-12. PubMed ID: 7002572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Letosteine in chronic obstructive bronchopneumopathy].
    Meroni P; Palmieri G; De Bartolo G; Barcellini W; Albrici A; Froldi M
    Clin Ter; 1983 Apr; 105(2):109-18. PubMed ID: 6345052
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparative trial of bromhexine HCl and oxytetracycline in acute and chronic bronchitis.
    Matts SG
    Br J Clin Pract; 1974 Dec; 28(12):403-5. PubMed ID: 4617590
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.